Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease

William W. Chu, Seung Woon Rha, Pramod K. Kuchulakanti, Edouard Cheneau, Rebecca Torguson, Rajbabu Pakala, Ellen E. Pinnow, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Ron Waksman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sirolimus-eluting stents (SESs; Cypher) have demonstrated a significant reduction in restenosis rates when compared to bare metal stents (BMSs). The purpose of this study was to evaluate the strategy of exclusive use of two SESs versus the combination of one BMS and one SES for two-vessel coronary artery disease (CAD). It was found that the selective use of one SES combined with one BMS in patients undergoing percutaneous coronary intervention that requires more than one stent is safe, feasible, and associated with favorable procedural, 30-day, and 6-month clinical outcomes when compared to the exclusive use of SESs.

Original languageEnglish
Pages (from-to)473-477
Number of pages5
JournalCatheterization and Cardiovascular Interventions
Volume65
Issue number4
DOIs
Publication statusPublished - 2005 Aug
Externally publishedYes

Keywords

  • Bare metal stent
  • Coronary artery disease
  • Sirolimus-eluting stent

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease'. Together they form a unique fingerprint.

  • Cite this

    Chu, W. W., Rha, S. W., Kuchulakanti, P. K., Cheneau, E., Torguson, R., Pakala, R., Pinnow, E. E., Pichard, A. D., Satler, L. F., Kent, K. M., Lindsay, J., & Waksman, R. (2005). Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease. Catheterization and Cardiovascular Interventions, 65(4), 473-477. https://doi.org/10.1002/ccd.20431